Showing results (61-70 of 190) with videos related to

Sort By:
Pageof 19
The CRISPR Journal|August 23, 2019
<i>VHL</i> Synthetic Lethality Signatures Uncovered by Genotype-Specific CRISPR-Cas9 ScreensNing Sun, Sakina Petiwala, Charles Lu, et al.
Head & Neck|November 22, 2012
High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes studyG Brandon Gunn, Tito R Mendoza, Clifton D Fuller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapyJoe Y Chang, Ritsuko Komaki, Ryohei Sasaki, et al.
Thyroid : Official Journal of the American Thyroid Association|October 28, 2016
Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid CarcinomaVlad C Sandulache, Michelle D Williams, Stephen Y Lai, et al.
Journal of Pain and Symptom Management|June 23, 2016
Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled TrialDavid Hui, Kelly Kilgore, Susan Frisbee-Hume, et al.
Head & Neck|March 28, 2017
Cohort study of oncologic emergencies in patients with head and neck cancerCielito C Reyes-Gibby, Stephanie C Melkonian, Ehab Y Hanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancerCharles Lu, Ritsuko Komaki, Jin Soo Lee, et al.
Investigational New Drugs|January 23, 2010
Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC)Hai T Tran, Ralph G Zinner, George R Blumenschein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markersCharles Lu, Jean-Charles Soria, Ximing Tang, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Enfortumab vedotin-induced cutaneous toxicities and their association with survival in urothelial carcinomaEudora Lee, Ralina Karagenova, Charles Lu, et al.
Pageof 19